Instrument Inactif

Communiqués Entest Group, Inc. Other OTC

Actions

21/01/20	ENTEST : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
07/01/20	ENTEST GROUP, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	AQ
20/12/19	ENTEST : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
10/05/18	Entest Group, Inc. : Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.	PR
13/09/17	Entest Biomedical : Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board	PR
31/05/17	Entest BioMedical : Settles $841,531 of Principal Indebtedness Through the Issuance of Equity Securities	PR